PCVX - Phathom Pharma Rhythm Vaxcyte most likely takeover targets in pharma - analyst
2024-04-07 08:00:00 ET
More on Phathom Pharmaceuticals
- Phathom: Undervalued Biotech With Possible GERD Treatment Label Expansion
- Phathom Pharmaceuticals, Inc. (PHAT) Q4 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Phathom Pharmaceuticals
- Historical earnings data for Phathom Pharmaceuticals
- Financial information for Phathom Pharmaceuticals